MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Swallowing sound index analysis using electronic stethoscope and artificial intelligence for patients with Parkinson’s disease

    R. Matsuyama, M. Nakamori, Y. Shimizu, O. Kikumoto, H. Maruyama (Hiroshima City, Japan)

    Objective: We investigated the swallowing sound index analyzed using an electronic stethoscope with artificial intelligence (AI) corresponds to the severity of Parkinson’s disease.(PD). Background: Several…
  • 2025 International Congress

    Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

    A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

    Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…
  • 2025 International Congress

    Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis

    S. Abdul-Ghani, J. Miles (Honolulu, USA)

    Objective: To investigate the prevalence of Parkinson disease and myasthenia gravis co-occurrence among hospitalized patients in the United States. Background: Parkinson disease (PD), a largely…
  • 2025 International Congress

    Supporting Movement Disorders Specialists with Digital Tools that Integrate with their Workflows

    J. Ikhile, V. Pandey (Salt Lake City, USA)

    Objective: Our work investigates how to design digital tools to assist movement disorders specialists in their clinical work. Background: Digital tools are ubiquitous in healthcare;…
  • 2025 International Congress

    Heterogeneity of the First Clinical Manifestations Reported in Patients with Early- and Late-Onset Parkinson’s Disease.

    J. Trejo-Ayala, H. Trujillo-Guerra, J. Sánchez-Garza, D. Ortiz-Zacarías, S. Castillo-Torres, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To compare the onset of clinical manifestations by location and motor or non-motor symptoms in patients with early- and late-onset Parkinson’s Disease (PD) from a movement…
  • 2025 International Congress

    The Impact of Metabolic Syndrome on Parkinson’s Disease Progression: A Systematic Review

    T. Denicol, C. Dagostini, MF. Felippe, G. Guindani Maia, G. Dal Alba, J. Sánchez León, A. Hilbig, C. Mello Rieder (Porto Alegre, Brazil)

    Objective: We aimed to identify the impact of Metabolic syndrome (MS) in motor and non-motor symptoms of Parkinson's disease (PD). Background: PD is a common…
  • 2025 International Congress

    Decline in Motor Function and Cognitive Abilities in GBA PD Compared to Idiopathic PD (iPD)

    B. Mangal, C. Edgar, O. Siddiqui, M. Facheris, M. Hagey, D. Weintraub, T. Simuni (Chicago, USA)

    Objective: To compare disease progression events between GBA PD and iPD using the Parkinson’s Progression Markers Initiative (PPMI) database Background: GBA PD patients exhibit more…
  • 2025 International Congress

    Impact of parkinson’s disease on work disability: a cross-sectional study

    S. Secades, C. Martin (Madrid, Spain)

    Objective: To evaluate the impact of Parkinson’s disease (PD) on work disability and identify clinical and demographic factors associated with occupational impairment. Additionally, this study…
  • 2025 International Congress

    Elucidating Tau and Alpha-synuclein Co-pathology in RAB39b X-linked Parkinson’s Disease.

    M. Kim, A. Park, E. Chiu, J. Weiss, S. Yu, D. Yearout, C. Zabetian, O. Betancour, M. Davis (Seattle, USA)

    Objective: Elucidate the mechanisms underlying pathogenesis of X-linked Parkinson’s disease (PD) due to the RAB39B p.G192R mutation. Background: RAB39B p.G192R causes X-linked PD with decreased…
  • 2025 International Congress

    The Impact of Microgravity and Herpes Simplex Virus 1 on Parkinson’s Neurodegeneration and HERV Expression

    ER. Simula, S. Jasemi, D. Cossu, I. Cossu, M. Fais, M. Noli, LA. Sechi (Sassari, Italy)

    Objective: The present abstract aims to investigate the impact of viral infections and microgravity exposure in the context of Parkinson’s disease (PD). Background: PD is…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley